首页> 美国卫生研究院文献>other >Molecular Mechanisms of Host-Pathogen Interactions and their Potential for the Discovery of New Drug Targets
【2h】

Molecular Mechanisms of Host-Pathogen Interactions and their Potential for the Discovery of New Drug Targets

机译:宿主-病原菌相互作用的分子机制及其发现新药靶标的潜力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Vaccines and chemotherapy have undeniably been the discoveries in the field of biomedical research that have exerted the biggest impact on the improvement of public health. Nevertheless, the development of bacterial resistance to antibiotics has co-evolved over time with the discovery of new drugs. This entails the necessity for continuous research on new anti-infectious agents.The current review highlights recent discoveries in the molecular mechanisms of specific host pathogen interactions and their potential for drug discovery. The focus is on facultative and obligate intracellular pathogens (Mycobacterium, Chlamydia and Legionella) and their manipulation of host cells in regard to inhibition of phagosome maturation and cell death. Furthermore, the composition and role of the SecA2 and the ESX-1 secretion pathways in bacterial virulence and manipulation of infected host cells is discussed. The central hypothesis proposed in this review is that the characterization of bacterial proteins and lipids involved in host cell manipulation (modulins) will provide an abundance of new drug targets. One advantage of targeting such bacterial modulins for drug development is that these anti-modulin drugs will not disrupt the beneficial host microflora and therefore have fewer side effects.
机译:不可否认,疫苗和化学疗法是生物医学研究领域中的发现,对改善公共卫生影响最大。然而,随着对新药的发现,细菌对抗生素的耐药性随着时间的推移而发展。这使得有必要对新的抗感染药进行持续研究。本综述着重介绍了特定宿主病原体相互作用的分子机制及其药物发现潜力的最新发现。重点是兼性和专性的细胞内病原体(分枝杆菌,衣原体和军团菌)及其对宿主细胞的操纵,以抑制吞噬体的成熟和细胞死亡。此外,讨论了SecA2和ESX-1分泌途径在细菌毒力和感染宿主细胞操纵中的组成和作用。在这篇综述中提出的中心假设是,宿主细胞操纵中涉及的细菌蛋白质和脂质(调节素)的表征将提供大量的新药物靶标。靶向这种细菌调节蛋白用于药物开发的一个优点是这些抗调节蛋白药物不会破坏有益的宿主微生物区系,因此副作用较小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号